Aethlon Medical, Inc.

NasdaqCM:AEMD Stock Report

Market Cap: US$4.0m

Aethlon Medical Past Earnings Performance

Past criteria checks 0/6

Aethlon Medical's earnings have been declining at an average annual rate of -17.5%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 4.4% per year.

Key information

-17.5%

Earnings growth rate

55.6%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate4.4%
Return on equity-160.9%
Net Margin-2,133.2%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

Aug 02
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

FDA approves protocol change in Aethlon's trial of its purifier to treat severe COVID

Jul 11

We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

Mar 18
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

We're Interested To See How Aethlon Medical (NASDAQ:AEMD) Uses Its Cash Hoard To Grow

Nov 09
We're Interested To See How Aethlon Medical (NASDAQ:AEMD) Uses Its Cash Hoard To Grow

Aethlon Medical climbs on Reddit interest

Jun 09

We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

May 12
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

We're Hopeful That Aethlon Medical (NASDAQ:AEMD) Will Use Its Cash Wisely

Jan 27
We're Hopeful That Aethlon Medical (NASDAQ:AEMD) Will Use Its Cash Wisely

Aethlon Medical has a new business and medical chief

Jan 06

Aethlon Medical (AEMD) rockets 63% as FDA amends Hemopurifier IDE for COVID-10 treatment

Dec 16

Aethlon names Charles J. Fisher, Jr., M.D. as CEO

Nov 03

Revenue & Expenses Breakdown
Beta

How Aethlon Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:AEMD Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231-12120
30 Sep 231-12120
30 Jun 231-12130
31 Mar 231-12120
31 Dec 220-13130
30 Sep 220-13130
30 Jun 220-11110
31 Mar 220-10110
31 Dec 210-990
30 Sep 211-9100
30 Jun 211-990
31 Mar 211-890
31 Dec 201-780
30 Sep 201-660
30 Jun 201-660
31 Mar 201-670
31 Dec 191-660
30 Sep 190-770
30 Jun 190-770
31 Mar 190-660
31 Dec 180-660
30 Sep 180-550
30 Jun 180-550
31 Mar 180-650
31 Dec 170-650
30 Sep 170-650
30 Jun 170-770
31 Mar 170-760
31 Dec 161-760
30 Sep 161-760
30 Jun 161-650
31 Mar 161-550
31 Dec 151-550
30 Sep 151-550
30 Jun 151-450
31 Mar 151-750
31 Dec 141-1350
30 Sep 141-1450
30 Jun 141-1750
31 Mar 142-1350
31 Dec 131-940
30 Sep 131-640
30 Jun 131-450

Quality Earnings: AEMD is currently unprofitable.

Growing Profit Margin: AEMD is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AEMD is unprofitable, and losses have increased over the past 5 years at a rate of 17.5% per year.

Accelerating Growth: Unable to compare AEMD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AEMD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).


Return on Equity

High ROE: AEMD has a negative Return on Equity (-160.94%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.